Get Botox in Only Three Places; Why Foreigners Are Flocking to Korea for Rejuran, Available Only in Korea, with Dr. Sung Hyun-cheol of Doctors Dermatology Sinsa Branch

보톡스 딱 3곳만 맞으세요. / 한국에서만 가능한 리주란, 외국인들이 몰려오는 이유 l 닥터스피부과 신사본점 성현철 원장
Watch on YouTube ↗  |  January 03, 2026 at 13:01  |  25:05  |  815 Money Talk (815머니톡)
Speakers
Sung Hyun-cheol — Director, Doctors Dermatology Sinsa Branch

Summary

This is a dermatology interview with Dr. Sung Hyun-cheol about cost-effective cosmetic procedures, covering Botox, Rejuran, laser toning, and Density. The discussion explains how each treatment works, who benefits, treatment cycles, side effects, and winter skincare. The only direct market-related mention is PharmaResearch, the listed company tied to Rejuran, whose stock is said to have corrected after a rally.

  • Dr. Sung discusses Botox as the highest value-for-money wrinkle treatment but warns that injection skill and side-effect risk matter.
  • Rejuran/PDRN is described as a skin-repairing treatment with Korea-only injectable approval and strong foreign-patient demand.
  • Laser toning is presented as a low-downtime pigment treatment for melasma and dermal pigmentation, with skin-sensitivity precautions.
  • Density is compared favorably with Thermage and Ultherapy on cost for mild-to-moderate skin laxity.
  • The guest notes Rejuran is best for thin, dry, sensitive skin and Density for thin skin with moderate laxity.
  • The only stock mention is PharmaResearch, which the guest says has fallen after a large rise.
  • Winter skincare advice includes drinking water and using inexpensive moisturizers such as Vaseline or Cetaphil.
Ideas
Sung Hyun-cheol Director, Doctors Dermatology Sinsa Branch 13:11
Rejuran's Korea-only approval aids PharmaResearch
PharmaResearch is the listed company linked to Rejuran. The guest explains that Rejuran/PDRN is approved for human injection in Korea but not yet by the U.S. FDA or in China, so foreign patients come to Korea for the treatment, creating a regulatory and medical-tourism demand angle. The stock-specific comment is only that the share price has fallen after a large rally, so this is a monitoring setup rather than a clear directional call.
Up Next

This 815 Money Talk (815머니톡) video, published January 03, 2026, features Sung Hyun-cheol discussing 214450.KQ. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: Sung Hyun-cheol  · Tickers: 214450.KQ